{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T15:13:45Z","timestamp":1768749225398,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.vaccine.2008.11.103","type":"journal-article","created":{"date-parts":[[2008,12,26]],"date-time":"2008-12-26T04:26:01Z","timestamp":1230265561000},"page":"1067-1072","source":"Crossref","is-referenced-by-count":41,"title":["Comparison of Montanide adjuvants, IMS 3012 (Nanoparticle), ISA 206 and ISA 35 (Emulsion based) alongwith incomplete Freund's adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom"],"prefix":"10.1016","volume":"27","author":[{"given":"Arun","family":"Waghmare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.L.","family":"Deopurkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milind","family":"Khadilkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milind","family":"Kalolikar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.K.","family":"Gade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.11.103_bib1","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/0041-0101(90)90155-Z","article-title":"Effect of snake antivenom proteins on blood platelets","volume":"28","author":"Kini","year":"1990","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2008.11.103_bib2","series-title":"Natural toxins-animal, plant and microbial","first-page":"25","article-title":"Tropical snake bite: clinical studies in south-east Asia","author":"Warrell","year":"1986"},{"key":"10.1016\/j.vaccine.2008.11.103_bib3","first-page":"788","article-title":"Srimannarayana\u2013rational use of antisnake venom","volume":"52","author":"Dutta","year":"2004","journal-title":"J Assoc Physicians India"},{"issue":"14","key":"10.1016\/j.vaccine.2008.11.103_bib4","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0264-410X(97)00098-4","article-title":"Production of highly potent horse antivenom against the Thai cobra (Naja kaouthia)","volume":"15","author":"Pratanaphon","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.103_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0035-9203(60)90213-3","article-title":"The toxicity & immunological properties of some sea snake venoms with particulars reference to that of Enhydrina schistosa","volume":"4","author":"Carey","year":"1960","journal-title":"Trans Roy soc, trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.11.103_bib6","series-title":"Snake venoms","first-page":"825","article-title":"Production and standardization of antivenin","author":"Christensen","year":"1979"},{"key":"10.1016\/j.vaccine.2008.11.103_bib7","first-page":"583","article-title":"Antivenom production in India","volume":"5","author":"Jadhav","year":"1991"},{"key":"10.1016\/j.vaccine.2008.11.103_bib8","first-page":"678","article-title":"A comparative study on different methods of hyperimmunization of horses for the preparation of polyvalent anti-snake venom serum","volume":"56","author":"Chatterjee","year":"1968","journal-title":"Ind J Med Res"},{"issue":"1","key":"10.1016\/j.vaccine.2008.11.103_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/14760584.1.1.111","article-title":"Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines","volume":"1","author":"Aucouturier","year":"2002","journal-title":"Expert Rev Vaccines"},{"issue":"13","key":"10.1016\/j.vaccine.2008.11.103_bib10","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0264-410X(96)00055-2","article-title":"International bank for foot\u2013and-month disease vaccine assessment of Montanide ISA25 and ISA206, two commercially available oil adjuvants","volume":"14","author":"Barnett","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.103_bib11","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/S0264-410X(02)00184-6","article-title":"Immuno response of goats against foot and mouth disease quadravalent vaccine: comparison of double oil emulsion and aluminium hydroxide gel vaccines in eliciting immunity","volume":"20","author":"Patil","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.103_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.vetmic.2004.09.006","article-title":"Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a proactive VapA candidate vaccine","volume":"104","author":"Cauchard","year":"2004","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.103_bib13","first-page":"493","article-title":"A simple method for estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2008.11.103_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2008.11.103_bib15","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmili","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2008.11.103_bib16","series-title":"Outline of veterinary clinical pathology","author":"Benjamin","year":"1985"},{"issue":"1","key":"10.1016\/j.vaccine.2008.11.103_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0041-0101(96)00077-3","article-title":"Clinical and laboratory alterations in horses during immunization with snake venom for the production of polyvalent (Crotalinae) antivenom","volume":"35","author":"Angulo","year":"1997","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.vaccine.2008.11.103_bib18","first-page":"1","article-title":"Studies on some hematological parameters of indian mules","volume":"14","author":"Gade","year":"2005","journal-title":"Indian J Vet Res"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2008.11.103_bib19","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.vaccine.2003.10.006","article-title":"Immunogenecity of sythentic peptides representing linear B-cell epitope of VapA of Rhodococcus equi","volume":"22","author":"Taouji","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.103_bib20","unstructured":"British Pharmacopoeia. European Viper Venom Antiserum 1998; pp. 2032."},{"key":"10.1016\/j.vaccine.2008.11.103_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-12-039233-9.50013-5","article-title":"Immunomodifiers in vaccines","volume":"33","author":"Altman","year":"1989","journal-title":"Adv Vet Sci Comp Med"},{"key":"10.1016\/j.vaccine.2008.11.103_bib22","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1016\/j.vaccine.2006.03.074","article-title":"Structure- and oil type-based efficacy of emulsion adjuvants","volume":"24","author":"Jansen","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.103_bib23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0041-0101(94)90204-6","article-title":"A Comparative study of three vehicles on antibody response against elepid snake neurotoxin immunogens","volume":"32","author":"Sunthornandh","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2008.11.103_bib24","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0041-0101(01)00108-8","article-title":"Production of potent polyvalent antivenom against three elapid venoms using a low dose, low volume, multi site immunization protocol","volume":"39","author":"Chotwiwatthanakun","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2008.11.103_bib25","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1016\/S0264-410X(00)00498-9","article-title":"Adjuvants designed for veterinary and human vaccines","volume":"19","author":"Aucouturier","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.103_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0022-1759(86)90402-3","article-title":"An adjuvant formulation that selectively elicit the formation of antibodies of protective isotypes and of cell-mediated immunity","volume":"95","author":"Allison","year":"1986","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2008.11.103_bib27","first-page":"983","article-title":"Mechanisms of action by immunologic adjuvants","volume":"181","author":"Osebold","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.11.103_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-2427(94)05413-M","article-title":"Comparison of adjuvants for immune potentiating properties and side effects in mice.","volume":"48","author":"Leenaars","year":"1995","journal-title":"Veterinary Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2008.11.103_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-4017(96)01043-6","article-title":"Comparative efficacy of Freund's and Montanide ISA50 adjuvant for the immunization of goats against heartwater with inactivated Cowdria ruminantum","volume":"67","author":"Martinez","year":"1996","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2008.11.103_bib30","first-page":"85","article-title":"Hyperimmunizacao de cavalos soroprodutores com venomos Botropios e Crotalico tratodos por glutaraldeido","volume":"51","author":"Quidolin","year":"1989","journal-title":"Mem Inst Butantan (Sao Paulo)"},{"key":"10.1016\/j.vaccine.2008.11.103_bib31","first-page":"557","article-title":"Antivenins in Brazil: preparation","volume":"5","author":"Raw","year":"1991"},{"key":"10.1016\/j.vaccine.2008.11.103_bib32","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0264-410X(99)00566-6","article-title":"A hepatitis B vaccine formulated with a novel adjuvant system","volume":"18","author":"Ambrosch","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.103_bib33","first-page":"227","article-title":"Sur Paugmentation anormale de Pantitoxine chez les chevaux producteurs de serum antidiphteique","volume":"101","author":"Ramon","year":"1925","journal-title":"Bull Soc Centr Med Vet"},{"key":"10.1016\/j.vaccine.2008.11.103_bib34","first-page":"1","article-title":"Procedres pour acroitre la production des antitoxins","volume":"40","author":"Ramon","year":"1926","journal-title":"Ann Inst Pasteur"},{"key":"10.1016\/j.vaccine.2008.11.103_bib35","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1016\/S0264-410X(99)00175-9","article-title":"Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA 720 adjuvant","volume":"17","author":"Saul","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.103_bib36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0041-0101(97)00160-8","article-title":"Venom, antivenoms and immunotherapy","volume":"36","author":"Chippaux","year":"1998","journal-title":"Toxicon"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08016824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08016824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T04:56:31Z","timestamp":1545540991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08016824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0264410X08016824"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.103","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}